Answer
Panitumumab has an elimination half-life of approximately 7.5 days (range 3.6–10.9 days) following the recommended regimen of 6 mg/kg every two weeks as a one-hour infusion.
Sources for this answer
- Vectibix 20 mg/mL concentrate for solution for infusionAmgen Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 27Document updated
Sources checked